Three claims are printed on the front of this bottle, and two of them are contradicted by the bottle they are printed on. Here is every one, with what it rests on.
Written by the Breathizen editorial team·Last updated October 11, 2026·How this page was checked
Breathizen prints three claims on the front of its bottle: Supports Clear Breathing, Natural Lung Support and Fast-Acting Spray. Not one of the three carries a dagger or an asterisk on the only product face supplied to this desk, and no FDA disclaimer is visible on that face. What they rest on is the difficulty. No Supplement Facts panel was supplied with this product in any form, and no amount is published for any of the five named ingredients, so there is nothing to set beside a trial dose. Of the five sources we opened, not one records a human respiratory finding: the European Medicines Agency approves mullein for traditional use only, for relief of sore throat, and for the flower rather than the leaf this product uses. Fast-Acting is contradicted by the brand's own review summary, which says most people wait three to six weeks. Spray is contradicted by the bottle, which has a black rubber-bulb dropper cap. What does hold up here is commercial rather than clinical: all three prices are published, a bottle is 100 days, and six bottles works out at $0.49 a day.
The front of this bottle is short and legible, which is more than can be said for a great many packs this desk has read. Three claim bars, one under the other, in the same type size.
Read at native resolution, they are: Supports Clear Breathing · Natural Lung Support · Fast-Acting Spray. Above them, the wordmark and the line OPEN YOUR BREATH. FEEL THE DIFFERENCE; below them a lung illustration, 2 oz / 60 ml and DIETARY SUPPLEMENT.
Not one of the three carries a dagger or an asterisk. The dagger is the mechanism by which a structure-function claim is tied to the disclaimer it should travel with — that the claim has not been evaluated by the Food and Drug Administration and the product is not intended to diagnose, treat, cure or prevent any disease. No such disclaimer is visible on the face we were shown.
We will be fair about the limits of that. No photograph of the back or base of this bottle was supplied to this desk, and a disclaimer may well be printed there. What we can report is what we were given: one face, three claims, no dagger, no disclaimer.
Then the third claim contradicts the object it is printed on. Fast-Acting Spray describes a sprayer. The bottle in every photograph supplied has a black rubber-bulb dropper cap — a pipette you squeeze. The brand's own How Breathizen Works graphic manages both at once, putting an ORAL SPRAY tile with a mist icon beside a BOTTLE LABEL tile with a dropper icon, around a photograph of a dropper.
And its first word is contradicted by the brand's own marketing. The review summary supplied with this product says most people wait three to six weeks. Both sentences came from the same envelope, and the gap between them is where a buyer's expectations get set.
The bottle. Always. It is the thing that has to be right in a way a landing page does not — which is exactly why the word Spray sitting on a dropper is the most serious line on this product.
On every other product this desk has read, this is where each claim is drawn against a printed amount. Here no such chart can exist, because no amount is published for any of the five. What the label does permit is days: 60 mL at 0.60 mL a day, against the sixty-day refund window.
On every other product this desk has read, this chart compares each printed amount with the dose its own research used. For this product that chart cannot exist. Five ingredients are named and not one carries a milligram figure, so there is no bar to draw for any of them.
What is drawn instead is the only numeric comparison this label makes possible: days of supply against the sixty-day refund window. Every figure comes either from the bottle — 60 mL at 0.60 mL a day — or from the brief’s own words.
The shape of it is the finding. Only one bar sits inside the window, and it is the thirty days of use the seller asks for before a claim. Everything you actually buy runs past it, and the cheapest pack runs ten times past it.
A period that sits inside the refund windowA period that runs past itThe full scale, 600 daysone shared linear scale — the upright mark on every row is the 60-day window
The first bar, and a permitted form of claim — with the disclaimer it should carry. What it rests on is the problem. Five named ingredients, no amount published for any of them, and five reference sources of which not one records a human respiratory finding. This claim rests on nothing a reader can check, and nothing we could check either.
“Natural” has no regulatory meaning here, and lung support is the closest this label comes to naming an organ — the bar a reader with a diagnosed airway condition is likeliest to read as a treatment. NCCIH: “Evidence does not support using complementary health approaches instead of proven medical management for asthma.”
Two problems in three words. Fast-acting is contradicted by the brand's own review summary, which says most people wait three to six weeks. Spray is contradicted by the bottle the words are printed on, which has a rubber-bulb dropper cap. Nothing supplied to this desk converts four pumps into a number of drops.
A real benefit, and the brand never claims it. The bottle is 2 oz / 60 mL and the serving is 0.60 mL, so 60 mL ÷ 0.60 mL = 100 days. The convention on this shelf is a thirty-day bottle, and a reader carrying that assumption misprices this by more than three times.
The cheapest per-day figure this desk has published. Six bottles at $294 is 600 days, so 49 cents a day. One bottle is $0.89 and three are $0.59. Not estimates: two published numbers divided by each other.
Also genuinely good, and rarer than it should be. $89, $177 and $294, with per-bottle figures of $89, $59 and $49. A great many products in this category publish nothing and defer every money question to the checkout screen.
It is worth writing the negatives down plainly, because the absence of a claim is much harder to notice than its presence.
Nobody can tell you how much of anything is in it. There is no Supplement Facts panel. None was supplied in any form and none appears in any artwork we were given. Five ingredients are named and zero carry an amount. The one numeral printed beside any of them, 10:1 on the mullein, is a concentration ratio and not a weight.
Nobody can tell you how often it works. No trial exists on this combination, so there is no response rate and no proportion of people who improved. Any figure of that kind you are shown has been invented.
Nobody can tell you it is fast. The front of the bottle says so; the brand's own review summary says three to six weeks. The longest of the ten supplied reviews runs to day 60 on a hundred-day bottle, and not one of the ten covers a full bottle.
Nobody can tell you it reaches a lung. The only regulatory assessment behind the headline ingredient is the European Medicines Agency's mullein monograph, whose approved indication is “relief of sore throat associated with dry cough and cold” — upper airway, during a cold, on traditional use only. It records “insufficient evidence from clinical trials”, and it covers the flower while this product uses the leaf.
Nobody can tell you it is safe with your medicines. No caution or warning panel of any kind was supplied — nothing on pregnancy, nursing, under-18s, medical conditions or prescription drugs — against two ingredients carrying documented interaction notes in the sources we opened.
And nobody has told us what four pumps means. The directions specify a measured 0.60 mL and the cap is a pipette. That conversion is not published.
No published trial exists on this combination, and because no amounts are printed, the usual check cannot be run at all. What we can report is what the reference sources say about the named ingredients, and on human breathing outcomes they are thin to adverse. The EMA approves mullein for traditional use only, for sore throat, and for the flower rather than the leaf in this bottle. NCCIH's ginger page covers nausea, cramps and knee osteoarthritis. The cordyceps summary says “doctors haven't studied them to see if they work.”
The front of the bottle says Fast-Acting. The review summary supplied by the same company says most people wait three to six weeks. Both of those came to this desk in the same delivery. Two of the ten supplied reviews say in their own words that it was slower than the page led them to expect.
No. NCCIH is explicit: “Evidence does not support using complementary health approaches instead of proven medical management for asthma.” This is a dietary supplement, not a rescue medicine. Two of the ten supplied reviews make the same point unprompted — one reports that her clinic told her to keep the inhaler.
Yes, and it would be dishonest to bury it. The price is transparent — all three tiers, per-bottle figures and struck prices were published up front, which many products in this category do not do. The cost per day is genuinely low at $0.49 on the six-pack, the lowest this desk has published. And the company publishes a phone number, two email addresses and two postal addresses.
One bottle is 100 days against a 60-day window, so no pack can be finished inside it. The smallest is still the smallest bet: $89, $0.89 a day, and the only one that does not commit you to years of a product whose amounts are not published.
The struck-through figures are $179, $537 and $1,074 — which is $179 multiplied by one, three and six. A crossed-out price is a claim about what something used to sell for, and no date is given on which this product sold at $179 a bottle. We print the struck figures because they are on the offer, and we print this note beside them because a reader deserves to know they are arithmetic rather than history. · window runs from purchase · no subscription · not for under 18, pregnancy or nursingWritten and fact-checked by The Breathizenres Editorial Desk, last updated October 11, 2026. A highlighted slot means that value has not been supplied yet and nothing has been invented in its place — why the reviewer line is empty.
